Healthcare / Health Information ServicesTokyo
$791.00
+9.00 (+1.17%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $1.4B · quality 55.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
36/100
D
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$19.3B
P/E
15.8x
↓EV/EBITDA
8.4x
↓ROE
23.1%
↑Gross Margin
65.2%
↑Debt/Equity
N/A
•TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+10.4%
FCF CAGR
+52.7%
FCF margin
22.2%
FCF / Net income
1.08x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $6.11B · net income $1.26B · FCF $1.36B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $6.11B | $6.11B | $5.84B | $5.19B | $4.54B |
| Net Income | $1.26B | $1.26B | $1.16B | $1.06B | $722.8M |
| EBITDA | $2.10B | $2.10B | $1.82B | $1.75B | $1.32B |
| EPS | — | — | — | 41.31 | 28.21 |
| Gross Margin | 65.2% | 65.2% | 60.8% | 64.1% | 60.0% |
| Operating Margin | 29.3% | 29.3% | 26.1% | 28.8% | 22.6% |
| Net Margin | 20.6% | 20.6% | 19.9% | 20.4% | 15.9% |
| Balance Sheet | |||||
| Current Ratio | 4.00 | 4.00 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $1.36B | $1.36B | $1.60B | $559.9M | $380.4M |
| Returns | |||||
| ROE | 23.1% | 23.1% | 20.7% | 21.9% | 17.9% |
| Valuation | |||||
| P/E | 15.80 | 15.80 | — | 24.21 | 16.91 |
| EV/EBITDA | 8.41 | 8.41 | 11.14 | 13.08 | 7.45 |
| P/B | 3.55 | 3.55 | 3.92 | 5.30 | 3.03 |
| Growth & Yield | |||||
| Revenue Growth | 4.6% | 4.6% | 12.5% | 14.3% | — |
| EPS Growth | — | — | — | 46.4% | — |
| Dividend Yield | 3.5% | 3.5% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+9.1%
Start / end P/E
n/dx → n/dx
EPS bridge
n/d → n/d
Residual
+5.6%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.